Jonathan Wadsley

11.9k citations
89 papers · 2.3k · 2 hit papers · h-index 21

Impact in

    • Gastrointestinal Tumor Research and Treatment
  • Oncology top 2%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Pancreatic and Hepatic Oncology Research 21
    • Colorectal Cancer Treatments and Studies 14
    • Esophageal Cancer Research and Treatment 10
    • Cholangiocarcinoma and Gallbladder Cancer Studies 6

Jonathan Wadsley

84 papers receiving 2.3k citations

Jonathan Wadsley's Hit Papers

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial 2013 · 413 citations
4130+4+8Years since publication100200300400500

Peers

Jonathan Wadsley
Comparison fields: 5 of 87
  • Gastroenterology 224
  • Oncology 928
  • Pulmonary and Respiratory Medicine 912
  • Surgery 767
  • Endocrinology, Diabetes and Metabolism 243
Replace Daisuke Takahari with:
Daisuke Takahari Japan
Matthew Nankivell United Kingdom
C.J.H. van de Velde Netherlands
Jae Moon Bae South Korea
Wasat Mansoor United Kingdom
Tae Sung Sohn South Korea
David Watkins United Kingdom
Margherita Nannini Italy
Inkeun Park South Korea
Sung Kim South Korea
Jonathan Wadsley relative to Daisuke Takahari Japan Daisuke Takahari's profile →
Citations per field
00.5×5.8×
Daisuke Takahari · 1×
Citations per year

Countries citing papers authored by Jonathan Wadsley

Since Specialization
Citations

This map shows the geographic impact of Jonathan Wadsley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Wadsley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Wadsley more than expected).

Fields of papers citing papers by Jonathan Wadsley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Wadsley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Wadsley. The network helps show where Jonathan Wadsley may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Wadsley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Wadsley Line = papers co-authored together Jonathan Wadsley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Hit paper breakdown →
2013551
2
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Hit paper breakdown →
2013413
3 2019154
4 2017134
5 2020112
6 201882
7 201380
8 201939
9 201238
10 201535
11 201931
12 200630
13 201928
14 200426
15 201725
16 201224
17 202124
18 202221
19 201320
20 201320

About Jonathan Wadsley

Jonathan Wadsley is a scholar working on Oncology, Surgery, Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Cancer Research, having authored 89 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (21 papers), Thyroid Cancer Diagnosis and Treatment (20 papers), Cancer Genomics and Diagnostics (16 papers), Colorectal Cancer Treatments and Studies (14 papers), Gastric Cancer Management and Outcomes (13 papers), Esophageal Cancer Research and Treatment (10 papers), Neuroendocrine Tumor Research Advances (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). The work is most often cited by research in Gastroenterology (224 citations), Oncology (928 citations), Pulmonary and Respiratory Medicine (912 citations), Surgery (767 citations) and Endocrinology, Diabetes and Metabolism (243 citations). Jonathan Wadsley has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include David Cunningham, Stephen Falk, Gary Middleton, Ian Chau, Fareeda Y. Coxon, Wasat Mansoor, Justin S. Waters, John Bridgewater, David González de Castro and Tom Crosby. Their work appears in journals such as Journal of Clinical Oncology, Clinical Oncology, Annals of Oncology, BMJ Open and Pancreatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact